Polaris DX Launches Igloo Pro, a Smart, Fast, Low-Cost Diagnostics Device Delivering Lab-Quality Results Onsite for Wellness Indicators Transforming Dental Surgery Outcomes

Designed in Germany by DX365 and built in Poland by a high-tech electronics manufacturer, Igloo Pro is a universal analysis platform, which can measure the level of markers such as Vitamin D, Ferritin (iron deficiency) and CRP (inflammation), for dentists and other healthcare professionals, ushering in a new era for rapid point-of-care testing (POCT). Timothy Ritson, Polaris DX’s CEO said: “Dentists are increasingly analysing client health indicators, including Vitamin D levels, prior to undertaking expensive dental procedures, such as implants. Many people in the UK are deficient in this essential nutrient which plays a critical role in maintaining healthy bones and teeth by promoting calcium absorption and helping to regulate levels of calcium and phosphorus in the blood. Igloo Pro provides dentists with a fast, easy-to-use, high-tech solution to analyse patients’ wellness markers on-site, enabling them to recommend supplements to improve these. Research suggests this may help improve patient recovery and lower failure rates following surgery.” Igloo Pro offers several unique features, which include: • Delivering tests on-site across a range of health indicators using single-use capillary assays providing laboratory quality results in minutes. • Negating the need for an in-house phlebotomist, anyone can be trained to use the machine. • Enhancing customer engagement by providing a new service. • Creating new revenue streams, not only charging for tests but also recommending supplements, products, and treatments immediately to the patient / customer while they are in clinic. Igloo Pro aims to replace the current pathology model in the UK which can be slow and time consuming and has a much higher negative environmental impact. The device is simple to use but it is also smart. The Igloo Pro stores clients’ results on the machine enabling these to be monitored over time and allowing for instant sharing – via messaging or email – with the client and other medical professionals. It is also linked to the DX365 laboratory via the cloud to enable real-time calibration of new tests as they are released and instant software updates ensuring that the platform is always optimised. Richard Pollock, Biological Dentist and Implant Surgeon, Chelsea Dental Clinic, concluded: “The strong benefits of being able to analyse Vitamin D levels and other key health markers on-site shouldn’t be underestimated. The Igloo Pro enables me to perform a simple capillary blood test to ascertain patients’ needs, and to then guide them as to which additional supplements they might require thereby optimising treatment. This capability is proving transformative in terms of patient outcomes.” The Igloo portfolio of approved capillary assays, which is continuously expanding, includes: • AMH Anti-Mullerian Hormone • CRP Inflammation value • cTnI Troponin Capillary • D-Dimer Blood Clots / Thrombosis • Ferritin Iron Content • FSH Follicle Stimulating Hormone • HbA1c Diabetes Management • LH Luteinizing Hormone • Nab Neutralising Antibody • Progesterone • TES Testosterone • TSH Thyroid Hormone • Vitamin D Vitamin D-25 Hydroxyvitamin These are sold in packs of 25 at price ranging from £10.00-£21.00. The Igloo Pro is being offered at a special launch price of £2,000 (list price £2,250) per unit at BDIA. Ends For more information: Emma Villiers +44 7799 133387 emmav@polarisdx.net